Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation. Journal title: Pharmacological Reports Authors: Aline Brando Lima, Alexandre Machado, Patrícia Simon, Moisés Cavalcante, Daniele Rezende, Gilberto S... Subject(s):
Reactive Oxygen Species and p38MAPK Have a Role in the Smad2 Linker Region Phosphorylation Induced by TGF-β Journal title: Iranian Journal of Medical Sciences Authors: Reyhaneh Niayesh Mehr, Alireza Kheirollah, Faezeh Seif, Parisa Dayati, Hossein Babaahmadi Rezaei Subject(s):
The Effect of Orally Administered Probiotics on the Behavioral, Cellular, and Molecular Aspects of Adjuvant-Induced Arthritis Journal title: Basic and Clinical Neuroscience Authors: Mahdi Shadnoush, Vida Nazemian, Homa Manaheji, Jalal Zaringhalam Subject(s):
Pioglitazone ameliorates retinal ischemia/reperfusion injury via suppressing NLRP3 inflammasome activities Journal title: International Journal of Ophthalmology Authors: Lin Liu Subject(s):
Role of the IL-33/ST2/p38 signaling pathway in the immune response of corneal epithelial cells to Aspergillus fumigatus infection Journal title: International Journal of Ophthalmology Authors: Gui-Qiu Zhao Subject(s):
